Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Treatment of Alzheimer's Disease.

GAAD Medical Research Institute Inc.1 site in 1 country4 target enrollmentFebruary 2008

ConditionsAlzheimer Disease

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Alzheimer Disease
Sponsor: GAAD Medical Research Institute Inc.
Enrollment: 4
Locations: 1
Primary Endpoint: Management and Cure of Alzheimer's Disease
Last Updated: 16 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Alzheimer's disease is a progressive and fatal brain disease. This study will investigate the use of far infrared radiation treatment for the disease.

Detailed Description

Alzheimer's destroys brain cells, causing problems with memory, thinking and behaviour severe enough to affect work, lifelong hobbies or social life. Alzheimer's gets worse over time and it is fatal. Alzheimer's, which has no current cure, is the most common form of dementia. It is hereby postulated that far infrared radiation of the central nervous and endocrine systems will help with the management of the disease and possibly cure the disease.

Registry

clinicaltrials.gov

Start Date

February 2008

End Date

April 2009

Last Updated

16 years ago

Study Type

Interventional

Study Design

Single Group